Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02112084 · ClinicalTrials.gov registry record · NA

An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death

A NA study of Cancer and Death, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
237
Enrollment target
1
Study location

NCT02112084 is a NA study of Cancer and Death that has completed, run by University of Utah. The registered enrollment target is 237 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02112084, a NA study of Cancer and Death, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
237 participants
Enrollment target
1
Study location

Study Summary

Individuals providing end-of-life caregiving to partners with terminal cancer often begin the bereavement process before the patient dies and with additional sources of stress. We know that grief for these partners can be long-term and impact virtually every aspect of their lives. This project will test the effectiveness of a new promising intervention that uses a dual process model (DPM) which focuses both on loss orientation (emotional loss and grief (referred to as LO)) and restoration orientation (learning new tasks of living that may have been the primary responsibility of the spouse who has died (referred to as RO tasks)).

Interventions

  • BEHAVIORAL Individualized DPM

Study Locations (1)

Utah

  • University of Utah College of Nursing - Salt Lake City

Trial Details

FieldValue
Enrollment Target 237 participants
Start Date 2010-05
Est. Completion 2017-04-30
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT02112084

The ClinicalTrials.gov registry entry for NCT02112084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Individualized DPM is the first listed.

NCT02112084 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT02112084 about?

NCT02112084 is a clinical study titled "An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death". Individuals providing end-of-life caregiving to partners with terminal cancer often begin the bereavement process before the patient dies and with additional sources of stress. We know that grief for these partners can be long-term and impact virtually every aspect of their lives. This project will ...

What is the current status of trial NCT02112084?

This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2010-05. Estimated completion is 2017-04-30.

What conditions does trial NCT02112084 study?

This clinical trial studies the following conditions: Cancer, Death, Bereavement.

What interventions are being tested in trial NCT02112084?

The interventions under investigation include: Individualized DPM (BEHAVIORAL).

Who is sponsoring clinical trial NCT02112084?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02112084 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.